PSV-AML

N/A

Report date: 2025/01/26 16:23:56

Base Information

Drug NamePSV-AML
Drug Alias NamePhosphoSynVaxPSV-AML
ClassificationBiologics > Antigen > Tumor antigenBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHeat-shock protein modulators
TargetsHeat-shock protein
Therapy Area/IndicationsLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAgenus Inc
China Registration ClassN/A

Develop Information

Active CompaniesAgenus Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A